- Filed
- Oct 24, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q3 2024 · Sep 30, 2024 | $84.64M |
| Long Term Debt | Q3 2024 · Dec 31, 2023 | $67.56M |
| Short Term Debt | Q3 2024 · Sep 30, 2024 | $10.06M |
| Short Term Debt | Q3 2024 · Dec 31, 2023 | $9.38M |
| Stockholders Equity | Q3 2024 · Sep 30, 2024 | $58.35M |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | $56.55M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $49.47M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $40.89M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $355.82M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $338.11M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $76.75M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $74.56M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $358.06M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $354.89M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $41.96M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2023 | $35.2M |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 24.89M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 24.27M sh |
| Stock Repurchased | Q3 2024 · Sep 30, 2023 | $0 |
| Capex | Q3 2024 · Sep 30, 2023 | $3.96M |
| Operating Cash Flow restated | Q3 2024 · Sep 30, 2023 | $37.37M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $0.28 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $0.43 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $0.29 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $0.44 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $14.83M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $48.02M |
| Net Income | Q3 2024 · Sep 30, 2023 | $6.93M |
| Net Income | Q3 2024 · Sep 30, 2023 | $10.52M |
| Operating Income | Q3 2024 · Sep 30, 2023 | $13.61M |
| Operating Income | Q3 2024 · Sep 30, 2023 | $26.27M |